Articles from BioResearch Compliance Report (February 1, 2007)

Title	Author	Type	Words
BiMo inspection FOIA log.		Brief article	193
CBER steps up test kit audits as CDER charts deficiencies from inspections; 3% are OAI.	Swain, Liz	Clinical report	796
Drug makers fail to begin 71% of promised post-marketing studies.	Mashaw, Rebecca		493
Duke IRB vice chair urges building safety into policy and procedures.	Swain, Liz		714
Errors on informed consent forms could lead to broader FDA review, inspector says.	Swain, Liz		538
FDA inspection should end with no surprises.	Swain, Liz		675
FDA, VA to share information on safe use of medical products.	Mashaw, Rebecca		305
Hoffman-La Roche cited for QA failures in 12-item 483.	Roche, Hoffman-La		523
Protocol and case history violations net 2-item 483 for CI.	Sarkane, Rudite		585
Warning letters.			641